Evidence map›Paper›PMID 42720713›Full record

ReviewClinical reviews in allergy & immunology2026

Molecular Signature and miRNA Pattern of CD4 + T Lymphocytes in Plaque Psoriasis.

Yelyzaveta Dubna, Katarzyna Nazimek

Abstract readReview
In one paragraph

Review in Clinical reviews in allergy & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yelyzaveta DubnaDepartment of Immunology, Jagiellonian University Medical College, Krakow, Poland.ORCID http://orcid.org/0009-0009-2390-8269
Katarzyna NazimekDepartment of Immunology, Jagiellonian University Medical College, Krakow, Poland. katarzyna.nazimek@uj.edu.pl.ORCID https://orcid.org/0000-0003-1302-117X

Funding

Polish Ministry of Science and Higher Education N41/DBS/001623
6 · The paper itself

Abstract

Psoriasis is a global health problem affecting approximately 3% of the population. Because this autoimmune and autoinflammatory disease significantly reduces the quality of life and carries the risk of serious complications and comorbidities, all efforts have been directed towards developing effective therapeutic strategies that allow for a significant restoration of immunological homeostasis. To make this possible, basic research is being conducted, among others, to discover the molecular basis responsible for the pathogenic activation of autoreactive lymphocytes. At the same time, microRNAs seem to be very interesting candidates for epigenetic modulation of signaling pathways disturbed in psoriasis, which are themselves also affected in its pathogenesis. Therefore, our narrative review comprehensively summarizes the current knowledge on the molecular signature and miRNA profile that appear characteristic for psoriasis-related CD4 + T lymphocytes and hypothesizes the effects of microRNA dysregulation based on the results of a contextual functional analysis of selected candidates having the greatest impact on the pathogenesis of psoriasis. Detailed considerations allowed us to uncover the most important signaling pathways and microRNA molecules active in pathogenic CD4 + T lymphocytes that are involved in psoriasis progression, and also suggested other microRNAs that appear to have potential therapeutic activity, with the leading opposing roles of interferon regulatory factor 4, microRNA-155 and microRNA-150.

Indexed as

CD4-Positive T-LymphocytesMicroRNAsPsoriasisAnimalsEpigenesis, GeneticGene Expression RegulationHumansInterferon Regulatory Factor-4Interferon Regulatory FactorsSignal TransductionInterferon Regulatory Factor-4Interferon Regulatory FactorsMicroRNAsCD4 + T LymphocytesIRF4miR-150miR-155PsoriasisTh17 Cells

Identifiers

PMID42720713
PMCPMC13562199

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.